Skip to main content
David Barbie, MD, Oncology, Boston, MA

DavidBarbieMD

Oncology Boston, MA

Assistant Professor, Medicine-Brigham & Women's Hospital, Harvard Medical School

Dr. Barbie is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Barbie's full profile

Already have an account?

  • Office

    450 Brookline Ave
    Dana 1234
    Boston, MA 02215
    Phone+1 617-632-3468
    Fax+1 617-632-5786

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2005 - 2008
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2002 - 2005
  • Harvard Medical School
    Harvard Medical SchoolClass of 2002

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2004 - 2025
  • NH State Medical License
    NH State Medical License 2024 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Genomic Correlates of Response to Immune Checkpoint Blockade in Microsatellite-Stable Solid Tumors  
    Jeffrey A Engelman, David A Barbie, Nicole G Chau, Glenn J Hanna, Natalie I Vokes, Sabina Signoretti, Pasi A Janne, Robert I Haddad, Lynette M Sholl, Rizwan Haq, Peter..., Nature
  • Tumor Innate Immunity Primed by Specific Interferon-Stimulated Endogenous Retroviruses  
    Scott Rodig, Ewa Sicinska, Thanh Uyen Barbie, David Allen Barbie, Russell William Jenkins, Ravindra Uppaluri, Rohit Thummalapalli, Jacob Sands, Nature

Press Mentions

  • Gut Bacteria Engineered to Act as Tumor GPS for Immunotherapies
    Gut Bacteria Engineered to Act as Tumor GPS for ImmunotherapiesOctober 4th, 2024
  • Health News - Experts Convene at CSHL to Scrutinize, Assess Low-Dose CT Screening for Lung Cancer
    Health News - Experts Convene at CSHL to Scrutinize, Assess Low-Dose CT Screening for Lung CancerFebruary 10th, 2016